EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC 4.0

Validation of a German version of the dementia screening questionnaire for individuals with intellectual disabilities (DSQIID‐G) in Down's syndrome

G Nuebling iD, O Wagemann, S Deb, E Wlasich, S V Loosli, K Sandkühler, A Stockbauer, C Prix, J Levin

Journal of Intellectual Disability Research · 2024

DOI: 10.1111/jir.13144 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Intellectual Disability Research, 2024. Verfasst von G Nuebling und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Ludwig-Maximilians University Munich, Munich, Germany. Hauptthemen laut MEDLINE: Down Syndrome, Psychometrics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Verum Foundation, Else Kröner-Fresenius Foundation, Stiftung VERUM.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

People with Down's syndrome (DS) are at high risk of developing Alzheimer dementia (DS‐AD) due to a triplication of the amyloid precursor protein gene. While several tools to diagnose and screen for DS‐AD, such as the dementia screening questionnaire for individuals with intellectual disabilities (DSQIID), are available in English, validated German versions of such instruments are scarce.

Methods

A German version of the DSQIID questionnaire (DSQIID‐G) was completed by caregivers before attending our specialist outpatient department for DS‐AD. All participants were assessed blind to DSQIID‐G scoring using clinical and neuropsychological examinations, including the Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and Others with Intellectual Disabilities (CAMDEX‐DS). ICD‐10 and amyloid/tau/neurodegeneration (A/T/N) criteria were applied to detect and categorise cognitive decline.

Results

Of 86 participants, 43 (50%) showed evidence of cognitive decline. A definite diagnosis of DS‐AD was reached in 17 (19.8%) and mild cognitive impairment in seven (8.3%) participants. Secondary causes of cognitive decline were determined among 13 (15.1%) participants, and in six (7%) cases, the diagnosis remained unclassifiable due to co‐morbidities. Compared with cognitively stable individuals, participants with cognitive decline ( n = 43) displayed higher DSQIID‐G total scores [median (range): 3 (0–21) vs. 19 (0–48), P < 0.001]. A total score of >7 provided a sensitivity of 0.94 against a specificity of 0.76, to discriminate DS‐AD and participants without cognitive decline according to ROC analysis. The convergent validity against the CAMDEX‐DS interview score was good ( r = 0.74), and split‐half reliability ( r = 0.96), internal consistency (Cronbach's α r = 0.96), test–retest reliability ( r = 0.88) ( n = 25) and interrater reliability ( r = 0.81) ( n = 31) were excellent.

Conclusions

The DSQIID‐G showed excellent psychometric properties, including concurrent and internal validity and reliability. The cut‐off value for screening was lower than in the original English validation study. For a screening instrument like DSQIID‐G, a lower cut‐off is preferable to increase case detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Down SyndromePsychometricsHumansMaleFemaleMiddle AgedAdultReproducibility of ResultsGermanyCognitive DysfunctionAgedIntellectual DisabilitySurveys and QuestionnairesDementiaAlzheimer Disease

Stichwörter der Autor:innen

Alzheimer diseaseDSQIIDDown's syndromediagnosisscreening

Autor:innen und Institutionen

  • Department of Neurology, Ludwig-Maximilians University Munich, Munich, Germany.
  • German Center for Neurodegenerative Disorders (DZNE), Site Munich, Munich, Germany.
  • Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK.
  • Munich Cluster for Systems Neurology, Munich, Germany.

ORCID-Profile: G Nuebling

Förderung

  • Verum Foundation
  • Else Kröner-Fresenius Foundation
  • Stiftung VERUM
  • Else Kröner-Fresenius-Stiftung

Zitieren

APA

Nuebling, G., Wagemann, O., Deb, S., Wlasich, E., Loosli, S. V., Sandkühler, K., Stockbauer, A., Prix, C., & Levin, J. (2024). Validation of a German version of the dementia screening questionnaire for individuals with intellectual disabilities (DSQIID‐G) in Down's syndrome. Journal of Intellectual Disability Research. https://doi.org/10.1111/jir.13144

Vancouver

Nuebling G, Wagemann O, Deb S, Wlasich E, Loosli SV, Sandkühler K, et al. Validation of a German version of the dementia screening questionnaire for individuals with intellectual disabilities (DSQIID‐G) in Down's syndrome. Journal of Intellectual Disability Research. 2024. doi:10.1111/jir.13144

BibTeX
@article{Nuebling2024,
  author = {Nuebling, G and Wagemann, O and Deb, S and Wlasich, E and Loosli, S V and Sandkühler, K and Stockbauer, A and Prix, C and Levin, J},
  title = {Validation of a German version of the dementia screening questionnaire for individuals with intellectual disabilities (DSQIID‐G) in Down's syndrome},
  journal = {Journal of Intellectual Disability Research},
  year = {2024},
  doi = {10.1111/jir.13144}
}
Kostenlos starten →